Think Research Corporation

TSXV:THNK Stock Report

Market Cap: CA$24.6m

Think Research Past Earnings Performance

Past criteria checks 0/6

Think Research's earnings have been declining at an average annual rate of -12.5%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 39.7% per year.

Key information

-12.5%

Earnings growth rate

11.9%

EPS growth rate

Healthcare Services Industry Growth-3.9%
Revenue growth rate39.7%
Return on equity-54.8%
Net Margin-18.0%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Feb 10
Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

Dec 18
Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Sep 06
Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Feb 28
Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Dec 01
Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Mar 30
Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Revenue & Expenses Breakdown
Beta

How Think Research makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:THNK Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2385-15348
30 Jun 2384-18347
31 Mar 2380-23367
31 Dec 2279-26367
30 Sep 2276-28389
30 Jun 2268-32389
31 Mar 2260-30358
31 Dec 2148-29338
30 Sep 2132-35277
30 Jun 2126-24206
31 Mar 2120-22166
31 Dec 2017-18136
30 Sep 2019-10175
30 Jun 2020-11176
30 Sep 1917-13157
30 Sep 1815-12168

Quality Earnings: THNK is currently unprofitable.

Growing Profit Margin: THNK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: THNK is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.

Accelerating Growth: Unable to compare THNK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: THNK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).


Return on Equity

High ROE: THNK has a negative Return on Equity (-54.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.